Nida Aslan Karakelle

Dr. Nida Aslan Karakelle

Faculty of Medicine, Physiology Department, Lokman Hekim Üniversitesi, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

12 December 2025 in BMC Neurology
Verified
Journal Article
Open access
EEEsra Eruyar
Esra Eruyar
YAYasemin Atıcı
Yasemin Atıcı
Nida Aslan KarakelleNida Aslan Karakelle
Nida Aslan Karakelle
SGSafiye Göçer
Safiye Göçer
Migraine is a common neurological disease that limits daily life. Researchers have proposed various mechanisms in the pathogenesis of migraine, including vascular dysfunction, neurogenic inflammation, oxidative stress, and stimulation of the trigeminovascular system. Studies consistently demonstrate the impact of oxidative stress and neurogenic inflammation on lipid metabolism. Although causality cannot be definitively established, several studies suggest that migraine may be associated with alterations in lipid metabolism, potentially resulting in an atherogenic lipid profile. This study aimed to investigate the status of oxidative stress and inflammation during the interictal phase of migraine and explore their potential impact on lipid metabolism. The Neurology outpatient clinic included fifty-seven migraine patients and thirty control cases. Migraine diagnosis and classification were made according to the International Classification of Headache Disorders (ICHD-3), with clear categorization into episodic or chronic migraine and migraine with aura (MWA) or without aura (MWoA). Serum levels of malondialdehyde (MDA, a marker of lipid peroxidation), glutathione (GSH, an antioxidant), NOD-like receptor family pyrin domain containing 3 (NLRP3, an inflammasome component), and nuclear factor kappa B (NF-κB, a proinflammatory transcription factor), as well as lipid parameters and headache characteristics, were assessed. CRP levels were measured via standard turbidimetric method; MDA and GSH were determined using spectrophotometric methods; NLRP3 and NF-κB were analyzed using ELISA kits per manufacturer protocols. In migraine patients, MDA and CRP levels significantly increased, while GSH and NLRP3 levels significantly decreased (p < 0.05). Subgroup analysis revealed that CRP and NLRP3 levels were significantly different between MWA and MWoA groups. Additionally, LDL levels were higher in patients with MWA. This study demonstrates a statistically significant association between elevated oxidative stress (increased MDA, decreased GSH), altered inflammatory response (elevated CRP, reduced NLRP3), and migraine. Differences between MWA and MWoA suggest subtype-specific pathophysiological mechanisms. Although this study supports a potential link between oxidative stress, inflammation, and lipid metabolism in migraine, they do not establish causality. These biomarkers may represent targets for future diagnostic and therapeutic strategies.

23 May 2023 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
ETEsra Tekin
Esra Tekin
Nida Aslan KarakelleNida Aslan Karakelle
Nida Aslan Karakelle
SDSibel Dinçer
Sibel Dinçer

13 August 2026 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
TGTayfun Göktaş
Tayfun Göktaş
SDSibel Dinçer
Sibel Dinçer
Nida Aslan KarakelleNida Aslan Karakelle
Nida Aslan Karakelle
GGGüleser Göktaş
Güleser Göktaş
Objectives: Cholestasis, characterized by impaired bile flow and bile accumulation, leads to progressive liver injury largely mediated by oxidative stress. Taurine, a conditionally essential amino acid with antioxidant and cytoprotective properties, may protect against cholestatic liver damage. This study investigated the effects of taurine in an experimental cholestasis model. Methods: Cholestasis was induced in rats by common bile duct ligation (BDL). Following surgery, animals received intraperitoneal saline or taurine (100 mg/kg). At designated time points, plasma and liver samples were collected. Oxidative stress parameters, including malondialdehyde (MDA), nitric oxide metabolites (NOx), and glutathione (GSH), were measured in plasma and liver tissue. Liver function was assessed by plasma alanine aminotransferase (ALT) and total bilirubin levels. Histopathological examination was performed to evaluate the extent of liver injury. Data were expressed as mean ± SD and analyzed using the Kruskal–Wallis test, with p<0.05 considered statistically significant. Results: Compared with saline-treated groups, taurine-treated rats exhibited significantly lower plasma and hepatic MDA and NOx levels and significantly higher GSH levels. Plasma ALT levels were also significantly reduced in taurine-treated animals. Although total bilirubin levels did not differ significantly at 24 h, they were significantly lower in taurine-treated rats at later time points. Histopathological analysis demonstrated progressive liver damage in untreated cholestatic rats, whereas taurine administration attenuated tissue injury and reduced the extent of damaged areas. Conclusions: Taurine effectively reduced oxidative stress and attenuated biochemical and histopathological liver injury in BDL-induced cholestasis. These findings suggest that taurine may be a promising adjunct therapeutic agent for cholestatic liver disease.

15 September 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Nida Aslan KarakelleNida Aslan Karakelle
Nida Aslan Karakelle
SGSafiye Göçer
Safiye Göçer
EEEsra Eruyar
Esra Eruyar
YAYasemin Atici
Yasemin Atici
MYMuge Coskun Yildirim
Muge Coskun Yildirim
Introduction: Alzheimer’s disease dementia (AD dementia) is a progressive neurodegenerative disorder associated with cognitive decline. Oxidative stress and inflammation may contribute to its pathophysiology, with clusterin (CLU) and sestrin-2 (SESN2) emerging as potential biomarkers. This study evaluated oxidative stress markers, inflammatory indices, and serum CLU and SESN2 levels in patients with AD dementia. Methods: A total of 48 patients with AD dementia and 39 healthy controls in a broadly comparable age range were enrolled from a neurology outpatient clinic. AD dementia was diagnosed according to internationally accepted clinical criteria. Cognitive function was assessed using Mini-Mental State Examination (MMSE) scores obtained at diagnosis. Serum malondialdehyde (MDA), glutathione (GSH), CLU, and SESN2 were measured, with MDA and GSH analyzed spectrophotometrically and CLU and SESN2 concentrations determined using the enzyme-linked immunosorbent assay (ELISA). Inflammatory indices were calculated from routine hematological and biochemical parameters. Results: A multivariable logistic regression model including age, MDA, and GSH showed excellent discriminatory performance for distinguishing patients with AD dementia from healthy controls. Patients with AD dementia had significantly lower SESN2 levels (p < 0.001) and higher CLU levels (p < 0.001) than controls. No significant associations were observed between inflammatory indices and the investigated clinical or biochemical variables in the AD dementia group (p > 0.05). Conclusions: Oxidative stress and altered SESN2 and CLU levels may be associated with AD dementia, whereas the inflammatory indices showed limited utility. Larger prospective studies are needed to validate these findings and clarify their clinical significance.